IRCT2014042017356N1.
Trial name or title | Effect of female sex hormones on traumatic brain injury |
Methods | RCT |
Participants | Inclusion criteria: diffuse TBI; men aged 18‐60 years with moderate to severe brain injury (GCS grades 3‐8 = severe and 9‐12 = moderate). Exclusion criteria: people with blunt head trauma; damage at an unknown time; entering the hospital > 4 hours after the time of damage; severe hypothermia (temperature less than 28 °C); aged < 18 years and > 60 years; candidates for craniotomy; diseases related to the immune system, gastrointestinal, oncology, infectious diseases, and other associated trauma |
Interventions | Intervention 1 (control group): routine and standard treatment only Intervention 2 (progesterone group): in addition to routine and standard treatment, within 4 hours of brain damage participants are given progesterone 1 mg/kg intramuscularly; dose is repeated every 12 hours for 5 consecutive days Intervention 3 (oestrogen group): in addition to routine and standard treatment, within 4 hours of brain damage participants are given a 40 µg oral oestrogen dose; dose is repeated daily for 5 consecutive days |
Outcomes | CRS‐R , FIM, GOS‐E, complications and adverse effects, difference GCS between admission and discharge times, length of stay, mortality |
Starting date | May 2014 |
Contact information | Dr Mohammad Khaksari, physiolojy@kmu.ac.ir. Department of Physiology, Afzalipour Medicine College, 22 Bahman Blvd. Kerman, Islamic Republic of Iran. |
Sponsors and Collaborators | Kerman Neuroscience Research Center |
Notes | Estimated enrollment: 90 participants |
Abbreviations
CRS‐R: coma recovery scale ‐ revised CT: computed tomography FIM: Functional Independence Measure GCS: Glasgow Coma Scale GOS: Glasgow Outcome Scale GOS‐E: extended Glasgow Outcome Scale ICP: intracranial pressure ITT: intention‐to‐treat analysis RCT: randomised controlled trial SF‐36: Short Form (36) health survey TBI: traumatic brain injury